Loading...
•
Aug 31, 2022
Tilray Q1 2023 Earnings Report
Reported net revenue at $153.2 million and maintained #1 cannabis market share in Canada and Germany.
Key Takeaways
Tilray Brands reported net revenue of $153.2 million for the first quarter of fiscal year 2023. The company maintained its #1 position in Canada with 8.5% cannabis market share and leads in medical cannabis within Germany. Tilray also realized $108 million in annualized cash cost-savings and expects to remove $130 million of costs from the business.
Reported net revenue was $153.2 million; on a constant currency basis, net revenue remained strong at $166.5 million.
Maintained #1 position in Canada with 8.5% cannabis market share.
International cannabis revenue was $10.4 million.
Achieved $108 million in annualized cash cost-savings since the closing of the Tilray – Aphria transaction in May 2021.
Forward Guidance
Tilray Brands reconfirms guidance to generate $70-$80 million of Adjusted EBITDA and be Free-Cash Flow Positive in its operating business units this fiscal year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...